PDL Biopharma (PDLI)

Earnings in 2020 (TTM): -A$0.2 Billion

According to PDL Biopharma 's latest financial reports the company's current earnings are A$80.61 Million. In 2019 the company made an earning of -A$93.56 Million a decrease over its 2018 earnings that were of -A$65.69 Million.

Earnings history for PDL Biopharma from 2001 to 2020

Annual earnings

Year	Earnings	Change
2020 (TTM)	-A$0.2 Billion	111.94%
2019	-A$93.56 Million	42.43%
2018	-A$65.69 Million	-121.38%
2017	A$0.30 B	60.41%
2016	A$0.19 B	-77.09%
2015	A$0.83 B	3.09%
2014	A$0.81 B	26.65%
2013	A$0.64 B	19.82%
2012	A$0.53 B	3.68%
2011	A$0.51 B	77.17%
2010	A$0.29 B	-35.29%
2009	A$0.44 B	23.45%
2008	A$0.36 B	-1751.42%
2007	-A$22.06 Million	-88.56%
2006	-A$0.2 Billion	93.73%
2005	-A$99.5 Million	13.63%
2004	-A$87.57 Million	32.12%
2003	-A$66.28 Million	87.44%
2002	-A$35.36 Million	-302.45%
2001	A$17.46 M

Earnings for similar companies or competitors

Company	Earnings	Earnings differencediff.	Country
Compugen CGEN	-A$41.37 Million	-79.05%	🇮🇱 Israel
Amgen AMGN	A$12.37 B	-6,366.58%	🇺🇸 USA
Nektar Therapeutics NKTR	-A$0.18 Billion	-13.51%	🇺🇸 USA
Eli Lilly LLY	A$33.77 B	-17,205.85%	🇺🇸 USA
Sangamo Therapeutics SGMO	-A$0.17 Billion	-17.13%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Earnings for PDL Biopharma (PDLI)

Earnings in 2020 (TTM): -A$0.2 Billion